Literature DB >> 15954124

Microglia in health and disease.

Seung U Kim1, Jean de Vellis.   

Abstract

Microglia, one of three glial cell types in the central nervous system (CNS), play an important role as resident immunocompetent and phagocytic cells in the CNS in the event of injury and disease. It was del Rio Hortega in 1927 who determined that microglia belong a distinct glial cell type apart from astrocytes and oligodendrocytes, and since 1970s there has been wide recognition that microglia are immune effectors in the CNS that respond to pathological conditions and participate in initiation and progression of neurological disorders including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and acquired immune deficiency syndrome dementia complex by releasing potentially cytotoxic molecules such as proinflammatory cytokines, reactive oxygen intermediates, proteinases and complement proteins. There is also evidence to suggest that microglia are capable of secreting neurotrophic or neuron survival factors upon activation via inflammation or injury. It is thus timely to review current status of knowledge on biology and immunology of microglia, and consider new directions of investigation on microglia in health and disease. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15954124     DOI: 10.1002/jnr.20562

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  215 in total

1.  Response of hippocampal neurons and glial cells to alternating magnetic field in gerbils submitted to global cerebral ischemia.

Authors:  Snežana Rauš; Vesna Selaković; Milica Manojlović-Stojanoski; Lidija Radenović; Zlatko Prolić; Branka Janać
Journal:  Neurotox Res       Date:  2012-06-06       Impact factor: 3.911

2.  Cloning and characterization of a novel gene encoding 16 kDa protein (Ac16) from Angiostrongylus cantonensis.

Authors:  Zheng-Yu Li; Zhi-Yue Lv; Jie Wei; Qi Liao; Huan-Qin Zheng; Zhong-Dao Wu
Journal:  Parasitol Res       Date:  2011-12-07       Impact factor: 2.289

3.  Ethyl pyruvate promotes spinal cord repair by ameliorating the glial microenvironment.

Authors:  Yimin Yuan; Zhida Su; Yingyan Pu; Xiujie Liu; Jingjing Chen; Feng Zhu; Yanling Zhu; Han Zhang; Cheng He
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

4.  Treatment for Helicobacter pylori infection and risk of Parkinson's disease in Denmark.

Authors:  H H Nielsen; J Qiu; S Friis; L Wermuth; B Ritz
Journal:  Eur J Neurol       Date:  2012-01-17       Impact factor: 6.089

Review 5.  Neurovascular unit: a focus on pericytes.

Authors:  Inês Sá-Pereira; Dora Brites; Maria Alexandra Brito
Journal:  Mol Neurobiol       Date:  2012-02-28       Impact factor: 5.590

Review 6.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-06-21       Impact factor: 3.584

Review 7.  Polyglutamine toxicity in non-neuronal cells.

Authors:  Jennifer W Bradford; Shihua Li; Xiao-Jiang Li
Journal:  Cell Res       Date:  2010-03-16       Impact factor: 25.617

8.  Responses of glial cells to stress and glucocorticoids.

Authors:  F Jauregui-Huerta; Y Ruvalcaba-Delgadillo; R Gonzalez-Castañeda; J Garcia-Estrada; O Gonzalez-Perez; S Luquin
Journal:  Curr Immunol Rev       Date:  2010-08-01

9.  Chemokines and their receptors in intracerebral hemorrhage.

Authors:  Yao Yao; Stella E Tsirka
Journal:  Transl Stroke Res       Date:  2012-04-03       Impact factor: 6.829

10.  Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.

Authors:  Makini K Cobourne-Duval; Equar Taka; Patricia Mendonca; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2018-05-04       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.